2Grabstein KH,Eisenman I,Shanebeck K,et al.Cloning of a T cell growth factor that interacts with the beta chain of the interleuk in-2 recepton.Science,1994,264:965-968.
5P.P.McDonald,M.P.Russo,S.Ferrini,et al.Interleukin-15 (IL-15) induced NF-kB activation and IL-8 production in human neutrophilis.Blood,1998,12:4828-4835.
1[1]Woodman R J, Watts G F, Puddey I B,et al. Leukocyte count and vascular function in type 2 diabetic subjects with treated hypertension[J]. Atherosclerosis,2002,163(1):175-181.
2[2]Franco C, Paola M, Paolo P,et al. White blood cell count is positively correlated with albumin excretion rate in subjects with type 2 diabetes[J]. Diabetes Care,2002,25(12):2354-2355.
3[3]WHO. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension[J]. J Hypertens,1999,17(2):151-183.
4[4]Mueller C, Neumann F J, Perruchoud A P, et al. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation [J]. Heart, 2003 ,89(4):389-392.
5[5]Hung M J, Cherng W J. Comparison of white blood cell counts in acute myocardial infarction patients with significant versus insignificant coronary artery disease[J]. Am J Cardiol, 2003,91(11):1339-1442.
6[6]Peter L, Paul M R, Attilio M. Inflammation and atherosclerosis[J]. Circulation,2002,105(9):1135-1143.
7[7]Hasegawa T, Negishi T, Deguchi M. WBC count, atherosclerosis and coronary risk factors[J]. J Atheroscler Thromb, 2002,9(5):219-223.
8[8]Aaron R F, Wayne D R, Eyal S, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke[J]. Circulation, 1999,100(7):736-742.
9UK Prospective Diabetes Study Group: Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33).Lancet 1998,352:837-853.
10The Diabetes Control and Complications Trials (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin - dependent diabetes mellitus. N Engl J Med 1993,329 : 977 - 986.
2Quinn Lebris S, Strait-Bodey Lena,Anderson Barbara G, et al. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway [ J ]. Cell Biol Int,2005,29 ( 6 ) : 449.
3Almendro V, Busquets S, Ametller E, et al. Effects of interleukin-15 on lipid oxidation: disposal of an oral [ (14) C ] -triolein load [ J ]. Biochim Biophys Acta, 2006,1761 (1) :37.
4Huang-Pin Wu, Sheng-Fong Kuo, Shao-Yun Wu, et al. High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients[ J]. Cytokine ,2010,51 (3) :298.
5Mishra Manish, Kumar Hemant, Bajpai Surabhi,et al. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes [ J ]. Diabetes Res Clin Praet, 2011, 94 (2) :255.
6Gverovi C Antuniea A, Karaman K, Znaor L, et al. IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients [ J ]. Graefes Arch Clin Exp Ophthalmol, 2012,250 ( 6 ) : 815.
